Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial

Patient preferences for oral versus intravenous palliative chemotherapy.

Geoffrey Liu, E. Franssen, Margaret I. Fitch et al. · Journal of Clinical Oncology · 1997 · 920 citations

Medicine, Oncology, Chemotherapy +14

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Andrew D. Seidman, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2008 · 604 citations · Full text

Medicine, Oncology, Pharmacology +17

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Fátima Cardoso, A. Costa, Larry Norton et al. · Annals of Oncology · 2014 · 539 citations · Full text

Medicine, Cancer Biology, Oncology +15

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

Marco Colleoni, Andrea Rocca, Maria Teresa Sandri et al. · Annals of Oncology · 2002 · 502 citations · Full text

Medicine, Oncology, Pharmacology +17

Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer

Silvia Dellapasqua, Francesco Bertolini, Vincenzo Bagnardi et al. · Journal of Clinical Oncology · 2008 · 293 citations

Medicine, Oncology, Pharmacology +15